Acquisition / mergerFiled on BSE ·
Sunteck Realty subsidiary acquires approx. 4.5 acres land in Borivali West
Sunteck Realty Ltd · Realty
What the filing says
- Acquisition by wholly owned subsidiary of Sunteck Realty Ltd.
- Land measures approximately 4.5 acres, adjacent to New Link Road, Borivali West, Mumbai.
- Transaction is not a related party transaction; disclosed on 5th October 2026.
Original filing
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('Listing Regulations')
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Sunteck Realty Ltd
- Acquisition / mergerSunteck Realty approves scheme with subsidiary and appoints Ernst & Young as auditor
- Acquisition / mergerSunteck Realty approves Scheme of Arrangement to demerge Satguru’s business
- Acquisition / mergerSunteck Realty approves scheme with Satguru and appoints EY as Internal Auditor
Other acquisition / merger filings this fortnight
- Acquisition / mergerKothari Petrochemicals LtdKothari Petrochemicals Ltd informs NSE on NCLT order for amalgamation scheme
- Acquisition / mergerVeranda LearningVeranda Learning announces Board constitution for J.K. Shah Commerce Education Limited
- Acquisition / mergerSai Parenteral'sSai Parenterals Limited completes acquisition of 60% stake in Prathyak Laboratories
- Acquisition / mergerDr Agarwals Eye Hospital LtdDr. Agarwal’s Eye Hospital files update on Scheme of Amalgamation with Dr. Agarwal’s Health Care
- Acquisition / mergerMaithan Alloys LtdMaithan Alloys Limited acquires 2,527,000 shares of HFCL Limited on 1st Oct 2026
- Acquisition / mergerDr Agarwal's HeaDr. Agarwal’s Health Care sanctioned NCLT merger with Dr. Agarwal’s Eye Hospital
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.